Wockhardt Drug Patent Portfolio
Wockhardt owns 1 orange book drug protected by 7 US patents Given below is the list of Wockhardt's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9657021 | Process For Preparation Of (2S, 5R)-7-Oxo-6-Sulphooxy-2[((3R)-Piperidine-3-Carbonyl)-Hydrazino Carbonyl]-1,6-Diaza-Bicyclo [3.2.1]-Octane | 12 Oct, 2033 | Active |
| US9834557 | Process For Preparation Of (2S, 5R)-7-Oxo-6-Sulphooxy-2-[((3R)-Piperidine-3-Carbonyl)-Hydrazino Carbonyl]-1,6-Diaza-Bicyclo [3.2.1]-Octane | 12 Oct, 2033 | Active |
| US8822450 | 1,6-Diazabicyclo [3,2,1] Octan-7-One Derivatives And Their Use In The Treatment Of Bacterial Infections | 24 Aug, 2032 | Active |
| US8853197 | 24 Aug, 2032 | Active | |
| US9132133 | Nitrogen Containing Compounds | 24 Aug, 2032 | Active |
| US9381200 | Nitrogen Containing Compounds | 24 Aug, 2032 | Active |
| US9827235 | Pharmaceutical Compositions Comprising Antibacterial Agents | 24 Aug, 2032 | Active |
Wockhardt's Family Patents
Recent FDA approvals and tentative approvals for Wockhardt
This section lists recent FDA approvals and tentative approvals for Lupin, covering innovator and generic drugs with key regulatory details and timelines.
Generic drugs
Includes generic drug submissions with tentative FDA approvals, not yet marketable due to patent or exclusivity restrictions.
| Drug Name | Submission class (FDA) | Submission Category | Submission Date |
|---|---|---|---|
| Duloxetine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 06 Jul, 2011 |
| Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 19 Oct, 2010 |
| Adenosine |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | - | 28 Apr, 2009 |
Wockhardt Drug List
Given below is the complete list of Wockhardt's drugs and the patents protecting them.
1. Zaynich
Zaynich is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9657021 | Process For Preparation Of (2S, 5R)-7-Oxo-6-Sulphooxy-2[((3R)-Piperidine-3-Carbonyl)-Hydrazino Carbonyl]-1,6-Diaza-Bicyclo [3.2.1]-Octane |
12 Oct, 2033
(7 years from now)
| Active |
| US9834557 | Process For Preparation Of (2S, 5R)-7-Oxo-6-Sulphooxy-2-[((3R)-Piperidine-3-Carbonyl)-Hydrazino Carbonyl]-1,6-Diaza-Bicyclo [3.2.1]-Octane |
12 Oct, 2033
(7 years from now)
| Active |
| US8822450 | 1,6-Diazabicyclo [3,2,1] Octan-7-One Derivatives And Their Use In The Treatment Of Bacterial Infections |
24 Aug, 2032
(6 years from now)
| Active |
| US8853197 |
24 Aug, 2032
(6 years from now)
| Active | |
| US9132133 | Nitrogen Containing Compounds |
24 Aug, 2032
(6 years from now)
| Active |
| US9381200 | Nitrogen Containing Compounds |
24 Aug, 2032
(6 years from now)
| Active |
| US9827235 | Pharmaceutical Compositions Comprising Antibacterial Agents |
24 Aug, 2032
(6 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zaynich's drug page